For nearly five decades, Patti Schultz's life was defined by mysterious and debilitating health conditions that caused her to feel isolated and discouraged. Her whirlwind of ...
By Mayo Clinic Alumni Magazine contributor We’re in the midst of a microbiome research epidemic, according to Purna Kashyap, M.B.B.S., co-associate director of the Microbiome Program in the Mayo Clinic Center ...
Thanksgiving Day marks Family Health History Day, an annual national public health campaign to encourage people to better understand what health characteristics run in their families. Has your mother, sister or grandmother had breast or ovarian cancer? Has your father had prostate cancer? Is there a history of colon cancer, diabetes or high cholesterol in your family? If so, you also could be at risk.
Does the human microbiome inhabit a natural pharmacy? Microorganisms are found in tissues and biofluids throughout the body, including in and around the gut, lungs, nose, ...
In a groundbreaking study published in The Lancet Digital Health, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better ...
The latest advances in exposomics, precision nutrition, metabolomics and cancer genomics were showcased on day two of Mayo Clinic's 11th Annual Individualizing Medicine Conference in ...
World-leading scientists highlighted their "exposomics" knowledge and discoveries during the first day of Mayo Clinic's 11th Annual Individualizing Medicine Conference in Rochester, Minnesota. Exposomics is ...
Unimaginable a decade ago, Mayo Clinic scientists have developed lab-grown miniature 3D brain models out of human cells to study opioid addiction and opioid treatment ...
ROCHESTER, Minn. – The next frontier in individualized medicine is here. Mayo Clinic's 11th annual Individualizing Medicine Conference on Nov. 2–3 will focus on "Exploring ...
By Kelley Luckstein An important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum Research Institute (LTRI) at Mount Sinai Hospital ...
In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting ...
By Gerri Kelly From Alzheimer's disease and asthma to diabetes and a chemotherapy drug, researchers at Mayo Clinic are tapping the Sangre Por Salud (Spanish for ...